PCOS Gets a Fresh Name: PMOS Aims to Improve Diagnosis and Care

Global experts have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its multisystem effects. The change, backed by 56 organizations after more than a decade of consultation and published in The Lancet, aims to reduce diagnostic delays and misperceptions by emphasizing endocrine and metabolic factors over ovarian cysts, potentially guiding future research toward metabolic roots like insulin resistance and chronic inflammation and reshaping how the condition is diagnosed and treated.